[N:1]1[S:5][N:4]=[C:3]2[C:6]([C:10]([C:12]3[N:13]=[CH:14][N:15](C(C4C=CC=CC=4)(C4C=CC=CC=4)C4C=CC=CC=4)[CH:16]=3)=O)=[CH:7][CH:8]=[CH:9][C:2]=12.C([SiH](CC)CC)C.FC(F)(F)C(O)=O>C(Cl)Cl>[NH:15]1[CH:16]=[C:12]([CH2:10][C:6]2[C:3]3=[N:4][S:5][N:1]=[C:2]3[CH:9]=[CH:8][CH:7]=2)[N:13]=[CH:14]1A solution of benzo[1,2,5]thiadiazol-4-yl-(1-trityl-1H-imidazol-4-yl)-methanone (Intermediate L3) (500 mg, 1.12 mmol) in methylene chloride (2 mL) was treated with triethylsilane (8 mL), and trifluoroacetic acid (8 mL) at rt for 48 h. This mixture was evaporated under vacuum and quenched with a ˜7M NH3-MeOH solution. The solvent was exchanged with CH2Cl2. The solution was concentrated onto silica gel and purified by chromatography, eluting with 3% NH3-MeOH:CH2Cl2 to give 4-(1H-imidazol-4-ylmethyl)-benzo[1,2,5]thiadiazole (Intermediate L4). 4-(1H-imidazol-4-ylmethyl)-benzo[1,2,5]thiadiazole (Intermediate L4) was subjected to the appropriate process steps in Method A to produce 4-benzo[1,2,5]thiadiazol-4-ylmethyl-1,3-dihydro-imidazole-2-thione (Compound 16).